GoodRx won't be participating with TrumpRx: report

[Telemedicine Company GoodRx]

* GoodRx (GDRX [https://seekingalpha.com/symbol/GDRX]), the company that provides a platform for consumers to get cheaper prescriptions drugs both online and at pharmacies, will not partner with TrumpRx, a federal government website that will connect consumers with lower-priced medications.
* CBS News Senior White Reporter Jennifer Jacobs said that a government official told her TrumpRx is designed to transfer patients to a particular drugmaker's website to make a discounted drug purchase. TrumpRx is expected to begin operations in January 2026.
* "The companies will decide how to fulfill those orders – via their own in-house logistics or by partnering with a 3rd-party platform," Jacobs wrote in an X post [https://x.com/JenniferJJacobs/status/1986518429478568383].
* A request for comment from GoodRx has yet to be returned to Seeking Alpha.
* Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), AstraZeneca (AZN [https://seekingalpha.com/symbol/AZN]), EMD Serono (OTCPK:MKGAF [https://seekingalpha.com/symbol/MKGAF]), and most recently, Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]), have agreed to participate in TrumpRx, part of the president's "Most Favored Nation" drug-pricing policy. In October, Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]) began offering [https://seekingalpha.com/news/4502044-amgen-to-offer-repatha-at-60-discount-to-us-consumers] its PCSK9 inhibitor cholesterol therapy Repatha (evolocumab) on its direct-to-consumer platform AmgenNow for $239 a month, a 60% discount of its list price.

MORE ON GOODRX HOLDINGS

* GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript [https://seekingalpha.com/article/4838547-goodrx-holdings-inc-gdrx-q3-2025-earnings-call-transcript]
* GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside [https://seekingalpha.com/article/4829177-goodrx-novo-deal-and-trumprx-talks-point-to-ebitdafcf-upside]
* GoodRx: Renewed Chance To Sign Up New Customers [https://seekingalpha.com/article/4823289-goodrx-renewed-chance-to-sign-up-new-customers]
* GoodRx outlines 35% manufacturer solutions growth for 2025 while expanding direct-to-consumer initiatives [https://seekingalpha.com/news/4516308-goodrx-outlines-35-percent-manufacturer-solutions-growth-for-2025-while-expanding-direct-to]
* GoodRx Holdings Q3 2025 Earnings Preview [https://seekingalpha.com/news/4513436-goodrx-holdings-q3-2025-earnings-preview]